Dyadic to attend bio ceo & investor conference and european industry events

Jupiter, fla., feb. 01, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following events during the month of february 2024.
DYAI Ratings Summary
DYAI Quant Ranking